News
Vir Biotechnology’s COVID-19 antibody research findings published in Nature
The paper, entitled “Cross-neutralization of SARS-CoV and SARS-CoV2 by a human monoclonal antibody” (Pinto, et al., Nature), details the identification and characterization of the antibody S309
MIT researchers find statistical approach to COVID-19 clinical trials that can accelerate drug approval process
MIT researchers have developed a framework that uses an epidemiological model of COVID-19 to calculate the optimal statistical threshold for approving a drug during a pandemic
